These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12212362)

  • 1. Short-chain fatty acids: bacterial mediators of a balanced host-microbial relationship in the human gut.
    Säemann MD; Böhmig GA; Zlabinger GJ
    Wien Klin Wochenschr; 2002 May; 114(8-9):289-300. PubMed ID: 12212362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary fiber on inflammatory bowel disease.
    Galvez J; Rodríguez-Cabezas ME; Zarzuelo A
    Mol Nutr Food Res; 2005 Jun; 49(6):601-8. PubMed ID: 15841496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of short-chain fatty acid metabolism in colonic disorders.
    Rabassa AA; Rogers AI
    Am J Gastroenterol; 1992 Apr; 87(4):419-23. PubMed ID: 1553927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions.
    Araki Y; Andoh A; Fujiyama Y; Itoh A; Bamba T
    Int J Mol Med; 2002 Jun; 9(6):627-31. PubMed ID: 12011980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
    Clavel T; Haller D
    Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the role of butyrate on colonic function.
    Hamer HM; Jonkers D; Venema K; Vanhoutvin S; Troost FJ; Brummer RJ
    Aliment Pharmacol Ther; 2008 Jan; 27(2):104-19. PubMed ID: 17973645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model.
    Bender A; Breves G; Stein J; Leonhard-Marek S; Schröder B; Winckler C
    Z Gastroenterol; 2001 Nov; 39(11):911-8. PubMed ID: 11778150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis.
    Lee M; Kovacs-Nolan J; Yang C; Archbold T; Fan MZ; Mine Y
    J Agric Food Chem; 2009 Mar; 57(6):2233-40. PubMed ID: 19231858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of diversion colitis with short-chain fatty acids. Bacteriological study].
    Neut C; Guillemot F; Gower-Rousseau C; Biron N; Cortot A; Colombel JF
    Gastroenterol Clin Biol; 1995 Nov; 19(11):871-5. PubMed ID: 8746044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in short-chain fatty acid metabolism.
    Elsen RJ; Bistrian BR
    Nutrition; 1991; 7(1):7-10; discussion 10-1. PubMed ID: 1802190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial mucosa cross-talk and pathophysiology of inflammation.
    Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S49-51. PubMed ID: 19300124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
    Xiao H; Gulen MF; Qin J; Yao J; Bulek K; Kish D; Altuntas CZ; Wald D; Ma C; Zhou H; Tuohy VK; Fairchild RL; de la Motte C; Cua D; Vallance BA; Li X
    Immunity; 2007 Apr; 26(4):461-75. PubMed ID: 17398123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial modulation of mucosal innate immunity.
    Kelly D; Conway S
    Mol Immunol; 2005 May; 42(8):895-901. PubMed ID: 15829279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria and mucosal immunity.
    Monteleone G; Peluso I; Fina D; Caruso R; Andrei F; Tosti C; Pallone F
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S256-60. PubMed ID: 17259086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microecology in chronic inflammatory bowel diseases.
    Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR
    Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
    Sun M; Wu W; Liu Z; Cong Y
    J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.